| |
 |
|
Class Information
Number: 514/356
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > C=o bonded directly to the six-membered hetero ring > At 3-position > C=o in a c(=o)o group (e.g., nicotinic acid, etc.)
Description: Subject matter wherein the C=O is part of aO group.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5559139 |
Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and its pharmaceutical use |
Sep. 24, 1996 |
| 5559134 |
Leukotriene-B.sub.4 antagonists, process for their production and their use as pharmaceutical agents |
Sep. 24, 1996 |
| 5556644 |
Nutritional supplement for the elderly |
Sep. 17, 1996 |
| 5552162 |
Method for improvement of scar size and appearance |
Sep. 3, 1996 |
| 5541220 |
Agents for the treatment and protection of the skin |
Jul. 30, 1996 |
| 5534502 |
Process for producing fat emulsion |
Jul. 9, 1996 |
| 5530001 |
Pharmaceutical use of dihydropyridine derivative |
Jun. 25, 1996 |
| 5525601 |
Composition for treating ocular pain |
Jun. 11, 1996 |
| 5519039 |
Composition and methods for treatment of acne vulgaris and for retardation of aging |
May. 21, 1996 |
| 5519012 |
Inclusion complexes of optically active 1,4-dihydropyridines with methyl-.beta.-cyclodextrin |
May. 21, 1996 |
| 5508293 |
Pyridinecarboxyimidamide compounds and the use thereof |
Apr. 16, 1996 |
| 5506224 |
N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes |
Apr. 9, 1996 |
| 5504081 |
Combating fish parasites |
Apr. 2, 1996 |
| 5502056 |
Caffeine containing composition |
Mar. 26, 1996 |
| 5500434 |
Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
Mar. 19, 1996 |
| 5494923 |
Method of ameliorating cerebral circulation |
Feb. 27, 1996 |
| 5491154 |
Pharmaceutical preparation for the oral administration of dihydropyridines |
Feb. 13, 1996 |
| 5478848 |
Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine |
Dec. 26, 1995 |
| 5472687 |
Topical pyridine N-oxides |
Dec. 5, 1995 |
| 5472970 |
Allylaminoesters and their application in therapeutics |
Dec. 5, 1995 |
| 5466690 |
Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
Nov. 14, 1995 |
| 5466690 |
Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
Nov. 14, 1995 |
| 5462951 |
Pharmaceutical composition containing slightly water-soluble drug |
Oct. 31, 1995 |
| 5459153 |
Composition and methods for treatment of acne vulgaris and for retardation of aging |
Oct. 17, 1995 |
| 5457132 |
Kit used in the treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers |
Oct. 10, 1995 |
| 5446057 |
Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists |
Aug. 29, 1995 |
| 5444053 |
Method for treating symptoms of Alzheimer's with NADH and NADPH |
Aug. 22, 1995 |
| 5444077 |
Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use |
Aug. 22, 1995 |
| 5444075 |
Penetration enhancers for transdermal delivery of systemic agents |
Aug. 22, 1995 |
| 5432185 |
Haemorheological use of N-alkylated 1,4-dihydropyridine-dicarboxylic acid esters, and some new compounds |
Jul. 11, 1995 |
| 5428046 |
Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments |
Jun. 27, 1995 |
| 5424321 |
Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
Jun. 13, 1995 |
| 5424323 |
Sterilant composition |
Jun. 13, 1995 |
| 5420145 |
Carboxylic acid derivative |
May. 30, 1995 |
| 5418245 |
Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase |
May. 23, 1995 |
| 5418244 |
Anticholinergic compounds, compositions and methods of treatment |
May. 23, 1995 |
| 5416114 |
Physiologically active and nutritional composition |
May. 16, 1995 |
| 5407949 |
Sterilant composition |
Apr. 18, 1995 |
| 5403845 |
Muscarinic agonists |
Apr. 4, 1995 |
| 5401759 |
Nimodipine enhanced growth and vascularization of neural grafts |
Mar. 28, 1995 |
| 5389623 |
Redox carriers for brain-specific drug delivery |
Feb. 14, 1995 |
| 5389654 |
3-ethyl 5-methyl(.+-.)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-d ihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate |
Feb. 14, 1995 |
| 5389644 |
1,4-dihydropyridine compounds |
Feb. 14, 1995 |
| 5385920 |
Diacylglycerol nicotinates |
Jan. 31, 1995 |
| 5380719 |
Quinoxaline biphenyl angiotensin II inhibitors |
Jan. 10, 1995 |
| 5378718 |
1,4-dihydropyridine derivatives |
Jan. 3, 1995 |
| 5358720 |
Treatment of arthritic conditions |
Oct. 25, 1994 |
| 5354765 |
Method of treatment for hypertension using combination therapy involving exogenous calcium and dihydropyridine calcium channel blockers |
Oct. 11, 1994 |
| 5348974 |
Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
Sep. 20, 1994 |
| 5344838 |
Sterilant composition |
Sep. 6, 1994 |
|
|
|
